Cargando…

Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response

Understanding the dynamics of host innate immune responses against a pathogen marks the first step toward developing intervention strategies against the pathogen. The cytosolic pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been shown to be the major innate immune sensor for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hingane, Smita, Joshi, Nishant, Surjit, Milan, Ranjith-Kumar, C. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174656/
https://www.ncbi.nlm.nih.gov/pubmed/32351484
http://dx.doi.org/10.3389/fmicb.2020.00656
_version_ 1783524669985390592
author Hingane, Smita
Joshi, Nishant
Surjit, Milan
Ranjith-Kumar, C. T.
author_facet Hingane, Smita
Joshi, Nishant
Surjit, Milan
Ranjith-Kumar, C. T.
author_sort Hingane, Smita
collection PubMed
description Understanding the dynamics of host innate immune responses against a pathogen marks the first step toward developing intervention strategies against the pathogen. The cytosolic pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been shown to be the major innate immune sensor for hepatitis E virus (HEV). Here, we show that HEV capsid protein (ORF2), a 660 amino acid long protein, interferes with the RIG-I signaling. Interestingly, only the full length ORF2 protein but not the 112-608 ORF2 protein inhibited RIG-I dependent interferon response. Both synthetic agonist and virus induced RIG-I activation was modulated by ORF2. Interference of interferon response was confirmed by reporter assays involving different interferon inducible promoters, qRT PCR, ELISA, and immunofluorescence microscopy. Neither glycosylation nor dimerization of the ORF2 protein had any effect on the observed inhibition. Further analyses revealed that the ORF2 protein antagonized Toll-like receptor (TLR) pathways as well. ORF2 inhibited signaling by RIG-I and TLR adapters, IPS-1, MyD88, and TRIF but was unable to inhibit activation by ectopically expressed IRF3 suggesting that it may be acting at a site upstream of IRF3 and downstream of adapter proteins. Our data uncover a new mechanism by which HEV may interfere with the host antiviral signaling.
format Online
Article
Text
id pubmed-7174656
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71746562020-04-29 Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response Hingane, Smita Joshi, Nishant Surjit, Milan Ranjith-Kumar, C. T. Front Microbiol Microbiology Understanding the dynamics of host innate immune responses against a pathogen marks the first step toward developing intervention strategies against the pathogen. The cytosolic pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been shown to be the major innate immune sensor for hepatitis E virus (HEV). Here, we show that HEV capsid protein (ORF2), a 660 amino acid long protein, interferes with the RIG-I signaling. Interestingly, only the full length ORF2 protein but not the 112-608 ORF2 protein inhibited RIG-I dependent interferon response. Both synthetic agonist and virus induced RIG-I activation was modulated by ORF2. Interference of interferon response was confirmed by reporter assays involving different interferon inducible promoters, qRT PCR, ELISA, and immunofluorescence microscopy. Neither glycosylation nor dimerization of the ORF2 protein had any effect on the observed inhibition. Further analyses revealed that the ORF2 protein antagonized Toll-like receptor (TLR) pathways as well. ORF2 inhibited signaling by RIG-I and TLR adapters, IPS-1, MyD88, and TRIF but was unable to inhibit activation by ectopically expressed IRF3 suggesting that it may be acting at a site upstream of IRF3 and downstream of adapter proteins. Our data uncover a new mechanism by which HEV may interfere with the host antiviral signaling. Frontiers Media S.A. 2020-04-15 /pmc/articles/PMC7174656/ /pubmed/32351484 http://dx.doi.org/10.3389/fmicb.2020.00656 Text en Copyright © 2020 Hingane, Joshi, Surjit and Ranjith-Kumar. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Hingane, Smita
Joshi, Nishant
Surjit, Milan
Ranjith-Kumar, C. T.
Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
title Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
title_full Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
title_fullStr Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
title_full_unstemmed Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
title_short Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
title_sort hepatitis e virus orf2 inhibits rig-i mediated interferon response
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174656/
https://www.ncbi.nlm.nih.gov/pubmed/32351484
http://dx.doi.org/10.3389/fmicb.2020.00656
work_keys_str_mv AT hinganesmita hepatitisevirusorf2inhibitsrigimediatedinterferonresponse
AT joshinishant hepatitisevirusorf2inhibitsrigimediatedinterferonresponse
AT surjitmilan hepatitisevirusorf2inhibitsrigimediatedinterferonresponse
AT ranjithkumarct hepatitisevirusorf2inhibitsrigimediatedinterferonresponse